Skip to content

Effect of methylprednisolon on postoperative pain in femur Fracture

Effect of Intravenous methylprednisolon on postoperative pain in patients with intertrochanteric femur fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013051113182N1
Enrollment
82
Registered
2013-09-21
Start date
2012-10-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

One sided intertrochanteric femur fracture. Fractures of other parts of femur

Interventions

Intervention 1: Intervention in Trial group: intravenous 2 cc equal with 125 milligrams methylprednisolon (one dosage). Intervention 2: Intervention in Control group: 2 cc normal saline.
Treatment - Drugs
Placebo
Intervention in Trial group: intravenous 2 cc equal with 125 milligrams methylprednisolon (one dosage)
Intervention in Control group: 2 cc normal saline

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:age between 40-70; having writing and verbal ability; Exclusion criteria:S-A contraindication; Failure in previous S-A; having renal failure;having peptic ulcer; having diabetes I or II; Neuropathy in RA patients that have steroid or immunosupressive usage in previous 6 months; Marcaine, Methyl prednisolon, fenatanile sensitivity;Alcoholism;smoking/addiction;pregnant women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: at 4,6,12,24,36,48 hours after operation. Method of measurement: VAS.

Secondary

MeasureTime frame
Post operative neaseua and vomiting. Timepoint: post operative time. Method of measurement: via patients observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamid Reza Faiz

Tehran University of medical sciences

hrfaiz@tums.ac.ir+98 21 64351

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026